Modulation by sphingolipids of calcium signals evoked by epidermal growth factor

Receptor-activated breakdown of complex sphingolipids has been proposed as a mechanism for generating sphingoid base-containing putative second messenger molecules whose actions may modulate responses to extracellular signals. In human epidermoid carcinoma A431 cells, sphingosine (1-10 microM) by it...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of biological chemistry 1994-08, Vol.269 (34), p.21885-21890
Hauptverfasser: Hudson, P L, Pedersen, W A, Saltsman, W S, Liscovitch, M, MacLaughlin, D T, Donahoe, P K, Blusztajn, J K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 21890
container_issue 34
container_start_page 21885
container_title The Journal of biological chemistry
container_volume 269
creator Hudson, P L
Pedersen, W A
Saltsman, W S
Liscovitch, M
MacLaughlin, D T
Donahoe, P K
Blusztajn, J K
description Receptor-activated breakdown of complex sphingolipids has been proposed as a mechanism for generating sphingoid base-containing putative second messenger molecules whose actions may modulate responses to extracellular signals. In human epidermoid carcinoma A431 cells, sphingosine (1-10 microM) by itself had no effect on intracellular free calcium concentrations ([Ca2+]i), yet within seconds, markedly enhanced the epidermal growth factor (EGF)-evoked Ca2+ influx (by up to 2-fold), but failed to alter Ca2+ release from the intracellular stores. Ca2+ signals evoked by serum were not affected by sphingosine. The response to sphingosine was dose-dependent and saturable, exhibiting an EC50 of 2.3 microM. In contrast, a ceramide, N-acetylsphingosine (10 microM), sphingosine 1-phosphate (10 microM), and sphingosylphosphorylcholine (10 microM) inhibited EGF-evoked elevations in [Ca2+]i. The latter two compounds by themselves transiently increased [Ca2+]i. N-Octanoylsphingosine, N,N-dimethylsphingosine, sphingomyelin, and stearylamine were inactive. The potentiation of calcium signals by sphingosine occurred at all concentrations of EGF tested (0.15-15 nM) and did not alter the EGF receptor protein kinase activity as determined by antiphosphotyrosine immunoblotting. Antiphosphoserine immunoblotting revealed that sphingosine (10 microM for 3 min) increased the phosphoserine content of two proteins with approximate molecular masses of 40 and 70 kDa. Serine hyperphosphorylation of the 40-kDa protein was also observed in cells treated with EGF alone, whereas the intensity of the 70-kDa band was highest in cells treated with both sphingosine and EGF. The modulation of growth factor receptor-regulated signaling, including changes in [Ca2+]i, may constitute a mechanism by which elevations in cellular levels of specific sphingolipids, which occur transiently upon activation of certain receptors and chronically in sphingolipid storage diseases, exert their physiological and pathophysiological effects.
doi_str_mv 10.1016/S0021-9258(17)31885-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76675207</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76675207</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-e65099dafbc50e2d15d8e66dff4d3f6d78dc62a92d34ec19d1a6e6385b68cfe83</originalsourceid><addsrcrecordid>eNqFkMFu1DAQhq0KVLalj1ApB4ToIeCxY8c-ogpopVYgFSRulmOPN4ZkvdgJVd--2e6q185lDvP9M6OPkHOgH4GC_HRHKYNaM6E-QHvBQSlR6yOyAqp4zQX8fkVWz8gbclLKH7pUo-GYHCsqueJ8RX7cJj8PdoppU3UPVdn2cbNOQ9xGX6oUKmcHF-exKnG9sUOp8H_6i36H4oJgHu1QrXO6n_oqWDel_Ja8DguIZ4d-Sn59_fLz8qq--f7t-vLzTe0agKlGKajW3obOCYrMg_AKpfQhNJ4H6VvlnWRWM88bdKA9WInLz6KTygVU_JS83-_d5vRvxjKZMRaHw2A3mOZiWilbwWj7IghSMqlYs4BiD7qcSskYzDbH0eYHA9TslJsn5Wbn00BrnpQbveTODwfmbkT_nDo4Xubv9vM-rvv7mNF0MbkeR8OkNrwxbLeIPwJxSImq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16626824</pqid></control><display><type>article</type><title>Modulation by sphingolipids of calcium signals evoked by epidermal growth factor</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Hudson, P L ; Pedersen, W A ; Saltsman, W S ; Liscovitch, M ; MacLaughlin, D T ; Donahoe, P K ; Blusztajn, J K</creator><creatorcontrib>Hudson, P L ; Pedersen, W A ; Saltsman, W S ; Liscovitch, M ; MacLaughlin, D T ; Donahoe, P K ; Blusztajn, J K</creatorcontrib><description>Receptor-activated breakdown of complex sphingolipids has been proposed as a mechanism for generating sphingoid base-containing putative second messenger molecules whose actions may modulate responses to extracellular signals. In human epidermoid carcinoma A431 cells, sphingosine (1-10 microM) by itself had no effect on intracellular free calcium concentrations ([Ca2+]i), yet within seconds, markedly enhanced the epidermal growth factor (EGF)-evoked Ca2+ influx (by up to 2-fold), but failed to alter Ca2+ release from the intracellular stores. Ca2+ signals evoked by serum were not affected by sphingosine. The response to sphingosine was dose-dependent and saturable, exhibiting an EC50 of 2.3 microM. In contrast, a ceramide, N-acetylsphingosine (10 microM), sphingosine 1-phosphate (10 microM), and sphingosylphosphorylcholine (10 microM) inhibited EGF-evoked elevations in [Ca2+]i. The latter two compounds by themselves transiently increased [Ca2+]i. N-Octanoylsphingosine, N,N-dimethylsphingosine, sphingomyelin, and stearylamine were inactive. The potentiation of calcium signals by sphingosine occurred at all concentrations of EGF tested (0.15-15 nM) and did not alter the EGF receptor protein kinase activity as determined by antiphosphotyrosine immunoblotting. Antiphosphoserine immunoblotting revealed that sphingosine (10 microM for 3 min) increased the phosphoserine content of two proteins with approximate molecular masses of 40 and 70 kDa. Serine hyperphosphorylation of the 40-kDa protein was also observed in cells treated with EGF alone, whereas the intensity of the 70-kDa band was highest in cells treated with both sphingosine and EGF. The modulation of growth factor receptor-regulated signaling, including changes in [Ca2+]i, may constitute a mechanism by which elevations in cellular levels of specific sphingolipids, which occur transiently upon activation of certain receptors and chronically in sphingolipid storage diseases, exert their physiological and pathophysiological effects.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1016/S0021-9258(17)31885-9</identifier><identifier>PMID: 8063833</identifier><language>eng</language><publisher>United States: American Society for Biochemistry and Molecular Biology</publisher><subject>Calcium - metabolism ; Carcinoma, Squamous Cell - metabolism ; Epidermal Growth Factor - pharmacology ; Humans ; Phosphorylation ; Protein-Serine-Threonine Kinases - metabolism ; Protein-Tyrosine Kinases - metabolism ; Second Messenger Systems - drug effects ; Sphingolipids - pharmacology ; Sphingosine - pharmacology ; Tumor Cells, Cultured</subject><ispartof>The Journal of biological chemistry, 1994-08, Vol.269 (34), p.21885-21890</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-e65099dafbc50e2d15d8e66dff4d3f6d78dc62a92d34ec19d1a6e6385b68cfe83</citedby><cites>FETCH-LOGICAL-c411t-e65099dafbc50e2d15d8e66dff4d3f6d78dc62a92d34ec19d1a6e6385b68cfe83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8063833$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hudson, P L</creatorcontrib><creatorcontrib>Pedersen, W A</creatorcontrib><creatorcontrib>Saltsman, W S</creatorcontrib><creatorcontrib>Liscovitch, M</creatorcontrib><creatorcontrib>MacLaughlin, D T</creatorcontrib><creatorcontrib>Donahoe, P K</creatorcontrib><creatorcontrib>Blusztajn, J K</creatorcontrib><title>Modulation by sphingolipids of calcium signals evoked by epidermal growth factor</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>Receptor-activated breakdown of complex sphingolipids has been proposed as a mechanism for generating sphingoid base-containing putative second messenger molecules whose actions may modulate responses to extracellular signals. In human epidermoid carcinoma A431 cells, sphingosine (1-10 microM) by itself had no effect on intracellular free calcium concentrations ([Ca2+]i), yet within seconds, markedly enhanced the epidermal growth factor (EGF)-evoked Ca2+ influx (by up to 2-fold), but failed to alter Ca2+ release from the intracellular stores. Ca2+ signals evoked by serum were not affected by sphingosine. The response to sphingosine was dose-dependent and saturable, exhibiting an EC50 of 2.3 microM. In contrast, a ceramide, N-acetylsphingosine (10 microM), sphingosine 1-phosphate (10 microM), and sphingosylphosphorylcholine (10 microM) inhibited EGF-evoked elevations in [Ca2+]i. The latter two compounds by themselves transiently increased [Ca2+]i. N-Octanoylsphingosine, N,N-dimethylsphingosine, sphingomyelin, and stearylamine were inactive. The potentiation of calcium signals by sphingosine occurred at all concentrations of EGF tested (0.15-15 nM) and did not alter the EGF receptor protein kinase activity as determined by antiphosphotyrosine immunoblotting. Antiphosphoserine immunoblotting revealed that sphingosine (10 microM for 3 min) increased the phosphoserine content of two proteins with approximate molecular masses of 40 and 70 kDa. Serine hyperphosphorylation of the 40-kDa protein was also observed in cells treated with EGF alone, whereas the intensity of the 70-kDa band was highest in cells treated with both sphingosine and EGF. The modulation of growth factor receptor-regulated signaling, including changes in [Ca2+]i, may constitute a mechanism by which elevations in cellular levels of specific sphingolipids, which occur transiently upon activation of certain receptors and chronically in sphingolipid storage diseases, exert their physiological and pathophysiological effects.</description><subject>Calcium - metabolism</subject><subject>Carcinoma, Squamous Cell - metabolism</subject><subject>Epidermal Growth Factor - pharmacology</subject><subject>Humans</subject><subject>Phosphorylation</subject><subject>Protein-Serine-Threonine Kinases - metabolism</subject><subject>Protein-Tyrosine Kinases - metabolism</subject><subject>Second Messenger Systems - drug effects</subject><subject>Sphingolipids - pharmacology</subject><subject>Sphingosine - pharmacology</subject><subject>Tumor Cells, Cultured</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMFu1DAQhq0KVLalj1ApB4ToIeCxY8c-ogpopVYgFSRulmOPN4ZkvdgJVd--2e6q185lDvP9M6OPkHOgH4GC_HRHKYNaM6E-QHvBQSlR6yOyAqp4zQX8fkVWz8gbclLKH7pUo-GYHCsqueJ8RX7cJj8PdoppU3UPVdn2cbNOQ9xGX6oUKmcHF-exKnG9sUOp8H_6i36H4oJgHu1QrXO6n_oqWDel_Ja8DguIZ4d-Sn59_fLz8qq--f7t-vLzTe0agKlGKajW3obOCYrMg_AKpfQhNJ4H6VvlnWRWM88bdKA9WInLz6KTygVU_JS83-_d5vRvxjKZMRaHw2A3mOZiWilbwWj7IghSMqlYs4BiD7qcSskYzDbH0eYHA9TslJsn5Wbn00BrnpQbveTODwfmbkT_nDo4Xubv9vM-rvv7mNF0MbkeR8OkNrwxbLeIPwJxSImq</recordid><startdate>19940826</startdate><enddate>19940826</enddate><creator>Hudson, P L</creator><creator>Pedersen, W A</creator><creator>Saltsman, W S</creator><creator>Liscovitch, M</creator><creator>MacLaughlin, D T</creator><creator>Donahoe, P K</creator><creator>Blusztajn, J K</creator><general>American Society for Biochemistry and Molecular Biology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TO</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>19940826</creationdate><title>Modulation by sphingolipids of calcium signals evoked by epidermal growth factor</title><author>Hudson, P L ; Pedersen, W A ; Saltsman, W S ; Liscovitch, M ; MacLaughlin, D T ; Donahoe, P K ; Blusztajn, J K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-e65099dafbc50e2d15d8e66dff4d3f6d78dc62a92d34ec19d1a6e6385b68cfe83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Calcium - metabolism</topic><topic>Carcinoma, Squamous Cell - metabolism</topic><topic>Epidermal Growth Factor - pharmacology</topic><topic>Humans</topic><topic>Phosphorylation</topic><topic>Protein-Serine-Threonine Kinases - metabolism</topic><topic>Protein-Tyrosine Kinases - metabolism</topic><topic>Second Messenger Systems - drug effects</topic><topic>Sphingolipids - pharmacology</topic><topic>Sphingosine - pharmacology</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hudson, P L</creatorcontrib><creatorcontrib>Pedersen, W A</creatorcontrib><creatorcontrib>Saltsman, W S</creatorcontrib><creatorcontrib>Liscovitch, M</creatorcontrib><creatorcontrib>MacLaughlin, D T</creatorcontrib><creatorcontrib>Donahoe, P K</creatorcontrib><creatorcontrib>Blusztajn, J K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hudson, P L</au><au>Pedersen, W A</au><au>Saltsman, W S</au><au>Liscovitch, M</au><au>MacLaughlin, D T</au><au>Donahoe, P K</au><au>Blusztajn, J K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Modulation by sphingolipids of calcium signals evoked by epidermal growth factor</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>1994-08-26</date><risdate>1994</risdate><volume>269</volume><issue>34</issue><spage>21885</spage><epage>21890</epage><pages>21885-21890</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>Receptor-activated breakdown of complex sphingolipids has been proposed as a mechanism for generating sphingoid base-containing putative second messenger molecules whose actions may modulate responses to extracellular signals. In human epidermoid carcinoma A431 cells, sphingosine (1-10 microM) by itself had no effect on intracellular free calcium concentrations ([Ca2+]i), yet within seconds, markedly enhanced the epidermal growth factor (EGF)-evoked Ca2+ influx (by up to 2-fold), but failed to alter Ca2+ release from the intracellular stores. Ca2+ signals evoked by serum were not affected by sphingosine. The response to sphingosine was dose-dependent and saturable, exhibiting an EC50 of 2.3 microM. In contrast, a ceramide, N-acetylsphingosine (10 microM), sphingosine 1-phosphate (10 microM), and sphingosylphosphorylcholine (10 microM) inhibited EGF-evoked elevations in [Ca2+]i. The latter two compounds by themselves transiently increased [Ca2+]i. N-Octanoylsphingosine, N,N-dimethylsphingosine, sphingomyelin, and stearylamine were inactive. The potentiation of calcium signals by sphingosine occurred at all concentrations of EGF tested (0.15-15 nM) and did not alter the EGF receptor protein kinase activity as determined by antiphosphotyrosine immunoblotting. Antiphosphoserine immunoblotting revealed that sphingosine (10 microM for 3 min) increased the phosphoserine content of two proteins with approximate molecular masses of 40 and 70 kDa. Serine hyperphosphorylation of the 40-kDa protein was also observed in cells treated with EGF alone, whereas the intensity of the 70-kDa band was highest in cells treated with both sphingosine and EGF. The modulation of growth factor receptor-regulated signaling, including changes in [Ca2+]i, may constitute a mechanism by which elevations in cellular levels of specific sphingolipids, which occur transiently upon activation of certain receptors and chronically in sphingolipid storage diseases, exert their physiological and pathophysiological effects.</abstract><cop>United States</cop><pub>American Society for Biochemistry and Molecular Biology</pub><pmid>8063833</pmid><doi>10.1016/S0021-9258(17)31885-9</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9258
ispartof The Journal of biological chemistry, 1994-08, Vol.269 (34), p.21885-21890
issn 0021-9258
1083-351X
language eng
recordid cdi_proquest_miscellaneous_76675207
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Calcium - metabolism
Carcinoma, Squamous Cell - metabolism
Epidermal Growth Factor - pharmacology
Humans
Phosphorylation
Protein-Serine-Threonine Kinases - metabolism
Protein-Tyrosine Kinases - metabolism
Second Messenger Systems - drug effects
Sphingolipids - pharmacology
Sphingosine - pharmacology
Tumor Cells, Cultured
title Modulation by sphingolipids of calcium signals evoked by epidermal growth factor
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T20%3A01%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Modulation%20by%20sphingolipids%20of%20calcium%20signals%20evoked%20by%20epidermal%20growth%20factor&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Hudson,%20P%20L&rft.date=1994-08-26&rft.volume=269&rft.issue=34&rft.spage=21885&rft.epage=21890&rft.pages=21885-21890&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1016/S0021-9258(17)31885-9&rft_dat=%3Cproquest_cross%3E76675207%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16626824&rft_id=info:pmid/8063833&rfr_iscdi=true